Connect with us

Health

New York Doctor Indicted in Louisiana for Sending Abortion Pills There

Published

on

New York Doctor Indicted in Louisiana for Sending Abortion Pills There

A state grand jury in Louisiana has indicted a New York doctor for providing abortion pills to a Louisiana resident. The case appears to be the first time criminal charges have been filed against an abortion provider for sending pills into a state with an abortion ban.

The charges mark a new chapter in an escalating showdown between states that ban abortion and those that want to protect and expand access to it. It is challenging one of the foremost strategies used by states that support abortion rights: shield laws intended to provide legal protection to doctors who prescribe and send abortion pills to states with bans.

The charges were brought against Dr. Margaret Carpenter, who was operating under New York’s telemedicine abortion shield law, which stipulates that New York authorities will not cooperate with prosecutions or other legal actions filed against New York abortion providers by other states.

Telemedicine abortion shield laws, which have been adopted by eight states so far, have become a significant avenue for providing access to abortion for women in states with bans without requiring them to leave their state. Doctors, nurse practitioners and other health care providers in states with shield laws have been sending more than 10,000 abortion pills per month to states with abortion bans or restrictions.

Legal experts said the case ratchets up the legal wars over abortion and will almost certainly end up in federal court and possibly the Supreme Court. It is expected to become a major test of whether states can apply criminal laws to people acting outside their borders.

Advertisement

Since the Supreme Court’s 2022 decision in Dobbs v. Jackson Women’s Health Organization overturning the national right to abortion, the United States has been divided between states that restrict abortion and states that protect abortion.

“There’s just been a sense that if you were in a blue state, you’re shielded from the consequences of Dobbs,” said Mary Ziegler, a law professor and abortion expert at the University of California, Davis. “Prosecutions like this undermine that assumption, and we don’t know exactly how, or how much, but you can’t take that for granted.”

Federal courts will have to sort out “where the line will be drawn and even which precedents the courts will be willing to overrule,” she said. “It’s not clear what will happen.”

The Louisiana indictment, by a grand jury in West Baton Rouge Parish, follows what is believed to be the first civil suit filed against an abortion provider in a shield-law state. That case was filed in December by the Texas attorney general, Ken Paxton, also against Dr. Carpenter, for prescribing and sending pills to a woman in Texas.

On Friday, Tony Clayton, the district attorney who oversees West Baton Rouge, said in an interview, “I just don’t know under what theory could a doctor be thinking that you should ship your pills to Louisiana to abort our citizens’ babies.”

Advertisement

He added: “The pill may be legal in New York. It’s not legal in Louisiana.”

In response to the charges, Gov. Kathy Hochul of New York said in a video posted on X, “I will never, under any circumstances, turn this doctor over to the state of Louisiana under any extradition request.” She pledged “to do everything I can to protect this doctor and allow her to continue the work that she’s doing that is so essential.”

The use of abortion medication has grown significantly in recent years. Medication abortions now account for nearly two-thirds of pregnancy terminations in the United States. The method is typically used through 12 weeks of pregnancy and involves two drugs — mifepristone, which stops a pregnancy from developing, followed a day or two later by misoprostol, which causes contractions similar to a miscarriage.

In 2021, the Food and Drug Administration lifted a rule requiring patients to obtain mifepristone in person, allowing the medication to be sent through the mail.

The ability to mail the medications, bolstered by shield laws, has made it much more difficult for states with bans to prevent their residents from getting access to abortion. The actions filed against Dr. Carpenter in Texas and Louisiana are part of a campaign to limit that access.

Advertisement

Abortion opponents are also pressing the Trump administration to revive a 151-year-old federal anti-vice law known as the Comstock Act and use it to try to prevent the mailing of abortion pills.

In the Louisiana case, the grand jury indicted Dr. Carpenter and her medical practice for “criminal abortion by means of abortion-inducing drugs.”

Dr. Carpenter, of New Paltz, N.Y., did not comment on the case on Friday, and efforts to reach lawyers representing her were unsuccessful.

The court documents, which include few details, indicate that the case involved a girl who was under 18 whose mother ordered abortion pills and gave them to her in April 2024. The mother was also charged with violating the state’s abortion ban.

Mr. Clayton, the West Baton Rouge district attorney, said the authorities became aware of the case after a police officer responded to a 911 call placed by the teenager.

Advertisement

“The officer at the time thought he was dealing with a child who was having a miscarriage,” Mr. Clayton said. After the police took the teenager to a hospital, the authorities learned that she had taken abortion medication and the investigation became criminal, he said.

Mr. Clayton, who declined to disclose the age or other details about the girl, said that “the evidence will show that the child had planned a reveal party” and did not want an abortion. He said that charges would not be filed against the girl.

Police records show that the mother, whose name The New York Times is not disclosing to protect the identity of her daughter, was arrested and released on bond. Attempts to reach her on Friday were unsuccessful.

“The allegations in this case have nothing to do with reproductive health care,” said Liz Murrill, the state attorney general. “This is about coercion. This is about forcing somebody to have an abortion who didn’t want one.”

The attorney general of New York, Letitia James, said in a statement, “This cowardly attempt out of Louisiana to weaponize the law against out-of-state providers is unjust and un-American.”

Advertisement

She added: “Medication abortion is safe, effective and necessary, and New York will ensure that it remains available to all Americans who need it.”

Dr. Carpenter is a specialist in reproductive health and a co-founder of the Abortion Coalition for Telemedicine, an organization that advocates access to telehealth abortion in all 50 states.

“Shield laws across the country enable licensed health care professionals to successfully deliver reproductive health care to patients in under-resourced areas nationwide,” the coalition said in a statement on Friday, adding, “This state-sponsored effort to prosecute a doctor providing safe and effective care should alarm everyone.”

Anti-abortion activists praised the Louisiana charges.

“This case exposes how mail-order abortion drugs are fueling an epidemic of coercion, a new form of domestic violence against mothers and their babies,” Katie Daniel, director of legal affairs for SBA Pro-Life America, said in a statement. The statement commended Louisiana for tightening laws against abortion medication and said, “In blue states, pro-abortion politicians are doing the polar opposite, shielding abortionists.”

Advertisement

In the Texas lawsuit, Dr. Carpenter was accused of providing abortion pills to a 20-year-old woman in July. The suit said the woman later asked the “biological father of her unborn child” to take her to the emergency room because of “severe bleeding,” and he learned at that time that she was nine weeks pregnant.

Mr. Paxton said that by filing the Texas lawsuit, he was seeking to have the court stop Dr. Carpenter from continuing to provide abortion medication to patients in Texas, and to apply Texas’ ban on abortion to her. The ban carries a penalty of at least $100,000 for each violation.

Kirsten Noyes contributed research.

Health

Dementia risk signals could lie in simple blood pressure readings, researchers say

Published

on

Dementia risk signals could lie in simple blood pressure readings, researchers say

NEWYou can now listen to Fox News articles!

Simple measurements taken during routine blood pressure checks could predict dementia risk years before symptoms appear.

That’s according to new research presented this week at the American College of Cardiology’s Annual Scientific Session in Louisiana.

The findings draw on two studies led by researchers at Georgetown University, which suggest that monitoring how blood vessels age and stiffen over time can provide a window into future cognitive health.

LURKING DEMENTIA RISK EXPOSED BY BREAKTHROUGH TEST 25 YEARS BEFORE SYMPTOMS

Advertisement

Data shows rates of dementia and aging-related cognitive decline are expected to increase as populations age, and half of U.S. adults have high blood pressure (hypertension).

Scientists believe that efforts to better address hypertension, a key contributor to heart disease and a risk factor for dementia, could affect both cardiac and brain health.

Data shows rates of dementia and aging-related cognitive decline are expected to increase as populations age. Meanwhile, half of U.S. adults have high blood pressure. (iStock)

“Blood pressure management isn’t just about preventing heart attacks and strokes; it may also be one of the most actionable strategies for preserving cognitive health,” Dr. Newton Nyirenda, the study’s lead author and an epidemiologist at Georgetown University in Washington, said in a press release.

The research focused on two metrics, the pulse pressure-heart rate index and estimated pulse wave velocity. Both were calculated using data collected during standard doctor visits, such as heart rate, age and blood pressure.

Advertisement

“Blood pressure management isn’t just about preventing heart attacks and strokes; it may also be one of the most actionable strategies for preserving cognitive health.”

Researchers examined five years of data patterns for more than 8,500 people in the SPRINT trial, a large study of adults 50 years and older with hypertension. In the follow-up, 323 of the participants developed probable dementia.

HIDDEN BRAIN CONDITION MAY QUADRUPLE DEMENTIA RISK IN OLDER ADULTS, STUDY SUGGESTS

In one study, the team found the pulse pressure-heart rate index was a strong independent predictor of dementia risk in adults over 50. For participants under 65, every one-unit increase was associated with a 76% higher risk of developing dementia.

For participants under 65, an increase in the pulse pressure-heart rate index was associated with a 76% higher risk of developing dementia. (iStock)

Advertisement

The second study found that adults with consistently elevated or rapidly increasing pulse wave velocity were more likely to develop dementia than those with stable velocity, even after accounting for factors like smoking, gender and cardiovascular history.

CLICK HERE FOR MORE HEALTH STORIES

“Our findings suggest that vascular aging patterns may provide meaningful insight into future dementia risk,” said Nyirenda. “This reinforces the idea that managing vascular health earlier in life may influence long-term brain health.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The team emphasized that clinicians should tailor risk assessments and treatment strategies to the individual.

Advertisement

Further studies are needed to confirm these parameters and determine whether changing vascular aging trajectories reduces dementia risk. (iStock)

“You don’t want to wait until a patient starts manifesting cognitive decline before you act,” said senior study author Sula Mazimba, an associate professor at the University of Virginia.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Researchers noted the study could not establish causation. Other limitations included the fact that participants already had hypertension and elevated cardiovascular risk, meaning the findings may not apply to people without those conditions.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

Further studies are needed to confirm these findings and to determine whether improving blood vessel health over time could reduce dementia risk.

Continue Reading

Health

Everything You Need To Know About Zepbound for Weight Loss, Including Costs

Published

on

Everything You Need To Know About Zepbound for Weight Loss, Including Costs


Advertisement





What Is Zepbound? Weight-Loss Benefits, Costs and Dosage




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

‘Gas station heroin’ banned in another state amid nationwide crackdowns

Published

on

‘Gas station heroin’ banned in another state amid nationwide crackdowns

NEWYou can now listen to Fox News articles!

A dangerous substance dubbed “gas station heroin” continues to alarm medical professionals, with more states making moves to restrict or ban tianeptine.

Fourteen states have officially classified the tricyclic antidepressant as a Schedule I controlled substance.

Connecticut is the latest state to crack down, officially banning the sale and use of the substance starting on Wednesday.

HEALTH OFFICIALS WARN OF DANGEROUS SUBSTANCE AVAILABLE IN STORES ACROSS THE NATION

Advertisement

Tianeptine, which can produce euphoria in higher doses, can be more potent than morphine and addictive opioids, according to the U.S. Food and Drug Administration.

Some countries have taken steps to restrict how tianeptine is prescribed or dispensed, and have even revised the labels to warn people of its potential addictive qualities.

Tianeptine can be more potent than morphine and addictive opioids. (iStock)

Misuse of tianeptine can cause severe adverse health effects, including respiratory depression, severe sedation and death, according to the Drug Enforcement Administration.

Some companies market the drug as an aid for pain, anxiety and depression, or as a means of improving mental alertness in a pill, powder, salt or liquid form.

Advertisement

The products are typically sold at convenience stores, gas stations, vape shops and online retailers, and go by names like Tianaa, ZaZa, Neptune’s Fix, Pegasus and TD Red.

Connecticut is the 15th state to classify tianeptine as a Schedule I controlled substance. (Markus Scholz/picture alliance via Getty Images)

Connecticut Lt. Gov. Susan Bysiewicz said in a press release that the schedule change is a necessary step to combat addiction.

“With false marketing that led consumers to believe these are safe products, and with candy-like flavor options, these substances posed a clear threat to those battling substance-use disorder and our youngest residents,” she added.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The Nutmeg State also added Mitragyna speciosa (kratom), 7-hydroxymitragynine, Bromazolam, Flubromazolam, Nitazenes and Phenibut to the schedule classification.

Earlier this month, FDA Commissioner Martin Makary penned a letter sounding the alarm on what he called a “dangerous and growing health trend.”

CLICK HERE FOR MORE LIFESTYLE STORIES

“I am very concerned,” Makary wrote. “I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America’s youth.”

Advertisement

New York-based Robert Schwaner, M.D., vice chair of system clinical affairs at Stony Brook Emergency Medicine, told Fox News Digital that the FDA has never approved tianeptine as a dietary supplement.

“As with heroin and other opioids, significant mu-opioid receptor stimulation ultimately results in a loss of respiratory drive and subsequent cardiac arrest.” (Dekalb County Sheriff’s Office)

“The euphoria at low doses is primarily due to increased serotonergic activity from its serotonin reuptake effects. With increasing doses, the mu-opioid receptor stimulation may become lethal,” said Schwaner. “As with heroin and other opioids, significant mu-opioid receptor stimulation ultimately results in a loss of respiratory drive and subsequent cardiac arrest.”

Schwaner said he believes the substance requires national regulation due to its addictive qualities. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“Acting at the same receptor as opioids, tianeptine has the potential for an individual to develop tolerance, subsequent dependence and withdrawal from its use,” he cautioned.

Fox News Digital reached out to the FDA for comment. 

Fox News Digital’s Greg Wehner and Melissa Rudy contributed to this report.

Continue Reading

Trending